JP2017504311A - 網膜色素上皮細胞を生成する方法 - Google Patents

網膜色素上皮細胞を生成する方法 Download PDF

Info

Publication number
JP2017504311A
JP2017504311A JP2016538000A JP2016538000A JP2017504311A JP 2017504311 A JP2017504311 A JP 2017504311A JP 2016538000 A JP2016538000 A JP 2016538000A JP 2016538000 A JP2016538000 A JP 2016538000A JP 2017504311 A JP2017504311 A JP 2017504311A
Authority
JP
Japan
Prior art keywords
cells
rpe
cultured
days
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016538000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017504311A5 (cg-RX-API-DMAC7.html
Inventor
チャウダリー パールー
チャウダリー パールー
サーマツ−コードレ ベアタ
サーマツ−コードレ ベアタ
ドーン エレン ブース ヘザー
ドーン エレン ブース ヘザー
ジョン ホワイティング ポール
ジョン ホワイティング ポール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Publication of JP2017504311A publication Critical patent/JP2017504311A/ja
Publication of JP2017504311A5 publication Critical patent/JP2017504311A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2016538000A 2013-12-11 2014-12-08 網膜色素上皮細胞を生成する方法 Pending JP2017504311A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361914445P 2013-12-11 2013-12-11
US61/914,445 2013-12-11
PCT/IB2014/066703 WO2015087231A1 (en) 2013-12-11 2014-12-08 Method for producing retinal pigment epithelial cells

Publications (2)

Publication Number Publication Date
JP2017504311A true JP2017504311A (ja) 2017-02-09
JP2017504311A5 JP2017504311A5 (cg-RX-API-DMAC7.html) 2018-01-25

Family

ID=52446403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538000A Pending JP2017504311A (ja) 2013-12-11 2014-12-08 網膜色素上皮細胞を生成する方法

Country Status (13)

Country Link
EP (1) EP3080248A1 (cg-RX-API-DMAC7.html)
JP (1) JP2017504311A (cg-RX-API-DMAC7.html)
KR (1) KR101871084B1 (cg-RX-API-DMAC7.html)
CN (1) CN105814194A (cg-RX-API-DMAC7.html)
AR (1) AR098693A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014363032A1 (cg-RX-API-DMAC7.html)
BR (1) BR112016012129A8 (cg-RX-API-DMAC7.html)
CA (1) CA2933083A1 (cg-RX-API-DMAC7.html)
HK (1) HK1221734A1 (cg-RX-API-DMAC7.html)
IL (1) IL245594A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016007671A (cg-RX-API-DMAC7.html)
TW (2) TW201823451A (cg-RX-API-DMAC7.html)
WO (1) WO2015087231A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501209A (ja) * 2014-11-21 2018-01-18 ライジェル ファーマシューティカルズ， インコーポレイテッド Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体
JPWO2021014515A1 (cg-RX-API-DMAC7.html) * 2019-07-19 2021-01-28
JP2022532411A (ja) * 2019-05-15 2022-07-14 ノヴォ ノルディスク アー／エス ヒト多能性幹細胞から眼野前駆細胞を得るための方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL273405B2 (en) * 2014-12-30 2024-01-01 Cell Cure Neurosciences Ltd Rpe cell populations and methods of generating same
EP3240890B1 (en) * 2014-12-30 2021-06-16 Cell Cure Neurosciences Ltd. Assessing retinal pigment epithelial cell populations
CA2972700A1 (en) * 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases
WO2017021973A1 (en) * 2015-08-05 2017-02-09 Cell Cure Neurosciences Ltd. Preparation of retinal pigment epithelium cells
AU2016321170B2 (en) * 2015-09-08 2022-09-01 Fujifilm Cellular Dynamics Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells
CN108291206B (zh) 2015-09-08 2022-07-08 富士胶片细胞动力公司 干细胞来源的视网膜色素上皮的基于macs的纯化
CN108350429B (zh) 2015-10-20 2022-02-25 富士胶片细胞动力公司 用于将多能干细胞定向分化为免疫细胞的方法
US20180362925A1 (en) * 2015-12-04 2018-12-20 Bond University Ltd Methods for differentiating cells
CN106344932B (zh) * 2016-08-26 2019-12-27 首都医科大学附属北京同仁医院 一种用于提高视网膜退行性疾病基因治疗效果的组合物及其应用
KR20190093199A (ko) 2016-12-07 2019-08-08 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 망막 색소 상피 이식을 위해 피브린 지지체를 사용하는 방법 및 물질
CN106906178A (zh) * 2017-04-07 2017-06-30 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 培养上皮细胞的组合物及其保持上皮样细胞形态中的应用
KR102668891B1 (ko) 2017-04-18 2024-05-29 후지필름 셀룰러 다이내믹스, 인코포레이티드 항원-특이적 면역 이펙터 세포
MX2019014503A (es) * 2017-06-05 2020-01-23 Mayo Found Medical Education & Res Metodos y materiales para cultivar, proliferar, y diferenciar celulas madre.
CN109957545A (zh) 2017-12-26 2019-07-02 江苏艾尔康生物医药科技有限公司 一种消化rpe细胞的方法
TW202012390A (zh) * 2018-06-29 2020-04-01 日商日本歐愛特農業科技股份有限公司 新穎之經取代吡唑衍生物
EP4008350A4 (en) 2019-07-26 2023-06-14 Saitama Medical University ANTIBODY RECOGNIZING THE EXTRACELLULAR REGION OF ALK2/ACVR1
CN113699097B (zh) * 2021-09-08 2023-06-09 湖南光琇高新生命科技有限公司 视网膜色素上皮细胞的制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG49267A1 (en) 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
US6045791A (en) 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5941250A (en) 1996-11-21 1999-08-24 University Of Louisville Research Foundation Inc. Retinal tissue implantation method
AU2003279132A1 (en) 2002-10-04 2004-05-04 Tissuetech, Inc. Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
SG10201912182UA (en) 2004-01-23 2020-02-27 Astellas Inst For Regenerative Medicine Improved modalities for the treatment of degenerative diseases of the retina
CA3015835A1 (en) 2004-11-04 2006-05-18 Astellas Institute For Regenerative Medicine Derivation of embryonic stem cells
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
CN101864392B (zh) 2005-12-13 2016-03-23 国立大学法人京都大学 核重新编程因子
JP5441099B2 (ja) 2007-01-18 2014-03-12 独立行政法人理化学研究所 視細胞への分化誘導方法
CA2684242C (en) 2007-03-23 2019-11-12 Wisconsin Alumni Research Foundation Somatic cell reprogramming
JP5395058B2 (ja) * 2007-04-18 2014-01-22 ハダシット メディカル リサーチ サーヴィシーズ アンド ディヴェロップメント リミテッド 幹細胞に由来する網膜色素上皮細胞
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
CA3177952A1 (en) 2007-10-12 2009-04-23 Astellas Institute For Regenerative Medicine Improved methods of producing rpe cells and compositions of rpe cells
GB0806746D0 (en) 2008-04-14 2008-05-14 Ucl Business Plc Membrane
CA3066806C (en) 2009-08-24 2023-03-07 David M. Gamm Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
WO2011063005A2 (en) 2009-11-17 2011-05-26 Advanced Cell Technology, Inc. Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
ES2542226T3 (es) 2010-04-28 2015-08-03 Technische Universität Dresden Método para producir células progenitoras retinianas polarizadas a partir de células madre pluripotentes y su diferenciación para dar células del epitelio pigmentario retiniano
EP3578988B1 (en) * 2010-05-25 2025-01-22 Memorial Sloan-Kettering Cancer Center Method of nociceptor differentiantion of human embryonic stem cells and uses thereof
GB201011313D0 (en) 2010-07-05 2010-08-18 Ucl Business Plc Implantation devices, methods and implants
EP3549617B1 (en) 2010-07-12 2023-09-13 University of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
US8871744B2 (en) 2010-07-21 2014-10-28 B & G Partyers, LLC Compounds and methods for selectively targeting tumor-associated mucins
CN102465111A (zh) * 2010-11-19 2012-05-23 薛志刚 一种体外人胚胎干细胞诱导分化为视网膜色素上皮细胞的试验方法
RU2590864C2 (ru) 2011-01-18 2016-07-10 МИНИПАМПЗ, ЭлЭлСи Хирургический инструмент для имплантации
WO2012177968A1 (en) 2011-06-22 2012-12-27 The Schepens Eye Research Institute, Inc. A scaffold for subretinal cell transplantation and drug delivery
HUE044778T2 (hu) 2011-11-14 2019-11-28 Astellas Inst For Regenerative Medicine Humán RPE sejt gyógyászati készítmények és alkalmazásaik
US9850463B2 (en) 2012-02-01 2017-12-26 The Regents Of The University Of California Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
CN102618488A (zh) * 2012-03-15 2012-08-01 中国人民解放军第三军医大学第一附属医院 一种制备视网膜色素上皮细胞的方法
ES2688019T3 (es) 2012-06-05 2018-10-30 The Regents Of The University Of California Métodos y composiciones para la producción acelerada de células epiteliales pigmentadas retinianas a partir de células pluripotentes
AU2014212230B2 (en) 2013-02-01 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARR, A.J.F., ET AL.: "Development of human embryonic stem cell therapies for age-related macular degeneration", TRENDS IN NEUROSCIENCES, vol. 36, no. 7, JPN6018041744, 2013, pages 385 - 395, XP055173782, ISSN: 0003904502, DOI: 10.1016/j.tins.2013.03.006 *
IDELSON, M., ET AL.: "Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium ce", CELL STEM CELL, vol. 5, no. 4, JPN6018041750, 2009, pages 396 - 408, XP055046648, ISSN: 0003904504, DOI: 10.1016/j.stem.2009.07.002 *
OSAKADA, F., ET AL.: "In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induct", JOURNAL OF CELL SCIENCE, vol. 122, no. 17, JPN6018041747, 2009, pages 3169 - 3179, XP002604161, ISSN: 0003904503, DOI: 10.1242/JCS.050393 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501209A (ja) * 2014-11-21 2018-01-18 ライジェル ファーマシューティカルズ， インコーポレイテッド Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体
JP2022532411A (ja) * 2019-05-15 2022-07-14 ノヴォ ノルディスク アー／エス ヒト多能性幹細胞から眼野前駆細胞を得るための方法
JPWO2021014515A1 (cg-RX-API-DMAC7.html) * 2019-07-19 2021-01-28
WO2021014515A1 (ja) * 2019-07-19 2021-01-28 東京エレクトロン株式会社 細胞の分化状態の評価方法
JP7344421B2 (ja) 2019-07-19 2023-09-14 東京エレクトロン株式会社 細胞の分化状態の評価方法

Also Published As

Publication number Publication date
WO2015087231A1 (en) 2015-06-18
CA2933083A1 (en) 2015-06-18
CN105814194A (zh) 2016-07-27
BR112016012129A2 (pt) 2017-08-08
AU2014363032A1 (en) 2016-06-09
MX2016007671A (es) 2016-10-14
BR112016012129A8 (pt) 2020-05-12
IL245594A0 (en) 2016-06-30
KR20160095118A (ko) 2016-08-10
EP3080248A1 (en) 2016-10-19
KR101871084B1 (ko) 2018-06-25
TW201538726A (zh) 2015-10-16
TW201823451A (zh) 2018-07-01
AR098693A1 (es) 2016-06-08
HK1221734A1 (zh) 2017-06-09

Similar Documents

Publication Publication Date Title
KR101871084B1 (ko) 망막 색소 상피 세포의 제조 방법
US20150159134A1 (en) Method for producing retinal pigment epithelial cells
US11560546B2 (en) Methods for neural conversion of human embryonic stem cells
JP6995314B2 (ja) 網膜組織の製造法
JP2022123137A (ja) ヒト多能性幹細胞からの機能的頭蓋プラコード派生体の特定
JP5721111B2 (ja) 幹細胞の培地及び培養方法
WO2016063985A1 (ja) 神経組織の製造方法
JP2010536357A (ja) 多能性幹細胞からのニューロン細胞の生成
AU2017214749B2 (en) Methods of differentiating stem cell-derived ectodermal lineage precursors
JP2014082956A (ja) 細胞培養基材、およびそれを用いた細胞培養方法並びに多能性幹細胞の分化誘導方法
JPWO2016013669A1 (ja) 腺性下垂体又はその前駆組織の製造方法
JP7766724B2 (ja) オリゴデンドロサイト前駆細胞組成物
Saito‐Diaz et al. Autonomic neurons with sympathetic character derived from human pluripotent stem cells
Klimanskaya Retinal pigment epithelium
Major et al. Derivation of telencephalic oligodendrocyte progenitors from human pluripotent stem cells
US20200199530A1 (en) Methods of differentiating stem cell-derived ectodermal lineage precursors
JP7737672B2 (ja) 下垂体ホルモン産生細胞及びその前駆細胞の分離法
AU2022355700A1 (en) Cell aggregate including pituitary hormone-producing cells and method for producing same
JP2022538503A (ja) ヒト多能性幹細胞由来の神経幹細胞株の生成
WO2024242069A1 (ja) 神経堤細胞の製造方法
US20220259558A1 (en) Methods for obtaining eye field progenitor cells from human pluripotent stem cells
WO2023054325A1 (ja) 細胞表面マーカーを用いた下垂体細胞および視床下部細胞の分離法
HK40086565A (en) Method for separating pituitary hormone-producing cells and progenitor cells thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171206

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190122

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190625